A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh.

Shyam SundarKrishna PandeyDinesh MondalMajor MadhukarRoshan Kamal TopnoAshish KumarVinod KumarDeepak Kumar VermaJaya ChakravartyRahul ChaubeyPoonam KumariMd Utba RashidShomik MarufPrakash GhoshSheeraz RajaJoelle RodeMargriet den BoerPradeep DasJorge AlvarSuman RijalFabiana Alves

Published in: PLoS neglected tropical diseases (2024)

CTRI/2017/04/008421.

Keyphrases

phase ii
open label
clinical trial
phase iii
study protocol
placebo controlled
double blind
wound healing